Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications

Diamand, Romain; Ploussard, Guillaume; Roumiguié, Mathieu; Malavaud, Bernard; Oderda, Marco; Gontero, Paolo; Fourcade, Alexandre; Fournier, Georges; Benamran, Daniel; Iselin, Christophe; Fiard, Gaelle; Descotes, Jean-Luc; Peltier, Alexandre; Simone, Giuseppe; Roche, Jean-Baptiste; Roumeguère, Thierry; Albisinni, Simone

doi:10.1016/j.urolonc.2020.08.030

Scientific article

English

Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications

ContributorsDiamand, Romain; Ploussard, Guillaume; Roumiguié, Mathieu; Malavaud, Bernard; Oderda, Marco; Gontero, Paolo; Fourcade, Alexandre; Fournier, Georges; Benamran, Daniel; Iselin, Christophe; Fiard, Gaelle; Descotes, Jean-Luc; Peltier, Alexandre; Simone, Giuseppe; Roche, Jean-Baptiste; Roumeguère, Thierry; Albisinni, Simone

Published inUrologic Oncology

Publication date2020

Abstract

Intermediate-risk prostate cancer regroups heterogeneous patients with different oncologic outcomes. Aim of the study is to validate a novel intermediate-risk subclassification ("magnetic resonance imaging [MRI] subclassification") that defines favorable and unfavorable diseases based on multiparametric MRI parameters and compare it to NCCN and AUA intermediate-risk subclassifications.

Keywords

Intermediate
MRI
Prostate cancer
Targeted biopsy
Unfavorable disease

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de chirurgie

Research groups

Groupe Iselin Christophe (urologie) (106)

Citation (ISO format)

DIAMAND, Romain et al. Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications. In: Urologic Oncology, 2020. doi: 10.1016/j.urolonc.2020.08.030

Article (Published version)

Supplemental data

Identifiers

PID : unige:151684
DOI : 10.1016/j.urolonc.2020.08.030
PMID : 33041188

Journal ISSN1078-1439

245views

0downloads

Creation21/10/2020 15:43:00

First validation21/10/2020 15:43:00

Update16/03/2023 00:35:17

Status update16/03/2023 00:35:15

Last indexation31/10/2024 22:06:35

Archive ouverte UNIGE

Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications

Technical informations